Valuation IDEXX Laboratories, Inc. Sao Paulo
Stocks
I1DX34
BRI1DXBDR001
Medical Equipment, Supplies & Distribution
|
Market Closed -
Sao Paulo
14:14:46 2026-11-19 EST
|
5-day change | 1st Jan Change | ||
| 816.02 BRL | +2.58% |
|
+3.01% | +8.04% |
| 11-17 | Rising vet bills drive more Americans to pet insurance | RE |
| 11-11 | IDEX Keeps Quarterly Dividend at $0.73 per Share, Payable Jan. 27, 2027, to Holders of Record Jan. 13 | MT |
Company Valuation: IDEXX Laboratories, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 55,833 | 33,786 | 46,098 | 33,854 | 54,022 | 54,335 | - | - |
| Change | - | -39.49% | 36.44% | -26.56% | 59.57% | 0.58% | - | - |
| Enterprise Value (EV) 1 | 56,612 | 35,022 | 46,592 | 34,434 | 54,690 | 54,693 | 54,157 | 53,749 |
| Change | - | -38.14% | 33.04% | -26.09% | 58.83% | 0.01% | -0.98% | -0.75% |
| P/E | 76.6x | 50.8x | 55.2x | 38.7x | 51.7x | 45.8x | 41x | 36.1x |
| PBR | 82.6x | 55.6x | 31x | 21.6x | 34.1x | 27.3x | 20x | 15.4x |
| PEG | - | -7.66x | 2.2x | 6.38x | 2.3x | 3x | 3.5x | 2.7x |
| Capitalization / Revenue | 17.4x | 10x | 12.6x | 8.69x | 12.6x | 11.4x | 10.5x | 9.61x |
| EV / Revenue | 17.6x | 10.4x | 12.7x | 8.83x | 12.7x | 11.5x | 10.5x | 9.51x |
| EV / EBITDA | 54.6x | 34.7x | 38.4x | 28.1x | 36.3x | 32.3x | 29x | 25.8x |
| EV / EBIT | 60.7x | 39x | 42.5x | 30.5x | 40.2x | 35.7x | 31.8x | 28.2x |
| EV / FCF | 89x | 88.9x | 60.3x | 42.6x | 51.7x | 46.3x | 41.1x | 36.6x |
| FCF Yield | 1.12% | 1.13% | 1.66% | 2.35% | 1.93% | 2.16% | 2.43% | 2.73% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 8.6 | 8.03 | 10.06 | 10.67 | 13.08 | 15.07 | 16.82 | 19.08 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 3,215 | 3,367 | 3,661 | 3,898 | 4,304 | 4,756 | 5,178 | 5,654 |
| EBITDA 1 | 1,037 | 1,011 | 1,212 | 1,225 | 1,505 | 1,696 | 1,871 | 2,080 |
| EBIT 1 | 932 | 898.8 | 1,097 | 1,128 | 1,360 | 1,533 | 1,702 | 1,903 |
| Net income 1 | 744.8 | 679.1 | 845 | 887.9 | 1,059 | 1,197 | 1,323 | 1,482 |
| Net Debt 1 | 779.2 | 1,236 | 493.9 | 579.3 | 667.8 | 357.6 | -178.1 | -586.1 |
| Reference price 2 | 658.46 | 407.96 | 555.05 | 413.44 | 676.53 | 689.65 | 689.65 | 689.65 |
| Nbr of stocks (in thousands) | 84,794 | 82,817 | 83,052 | 81,885 | 79,851 | 78,786 | - | - |
| Announcement Date | 2/2/22 | 2/6/23 | 2/5/24 | 2/3/25 | 2/2/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 34.36x | 4.07x | 15.29x | 2.5% | 180B | ||
| 21.78x | 3.7x | 13.25x | 2.82% | 123B | ||
| 27x | 4.8x | 16.47x | 1.15% | 119B | ||
| 31.03x | 3x | 12.07x | 2.3% | 89.18B | ||
| 18.1x | 0.22x | 13.5x | 0.7% | 65.12B | ||
| 43.35x | 3.83x | 13.03x | 1.97% | 57.93B | ||
| 45.78x | 11.5x | 32.26x | -.--% | 54.33B | ||
| 28.23x | 6.99x | 17.72x | 1.42% | 48.88B | ||
| 49.11x | 3.55x | 13.07x | 0.49% | 36.07B | ||
| Average | 33.19x | 4.63x | 16.30x | 1.48% | 86B | |
| Weighted average by Cap. | 31.25x | 4.34x | 15.70x | 1.79% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- IDXX Stock
- I1DX34 Stock
- Valuation IDEXX Laboratories, Inc.
Select your edition
All financial news and data tailored to specific country editions
















